Literature DB >> 20733583

Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases.

M A Sarzynski1, P Jacobson, T Rankinen, B Carlsson, L Sjöström, C Bouchard, L M S Carlsson.   

Abstract

PURPOSE: To test whether DNA sequence variation in 11 obesity genes is associated with maximum weight loss and weight regain over 6 years of follow-up in bariatric surgery patients of the Swedish obese subjects (SOS) intervention study.
METHODS: A total of 1443 subjects were available for analysis (vertical banded gastroplasty: n = 966, banding: n = 293 and gastric bypass: n = 184). Single-nucleotide polymorphisms (SNPs) from the following 11 genes were included: ADIPOQ, BDNF, FTO, GNB3, LEP, LEPR, MC4R, NR3C1, PPARG, PPARGC1A and TNF. General linear models were used to analyze associations between the SNPs and maximum weight loss and weight regain.
RESULTS: The average maximum weight loss was 33.7 kg (s.d. 13.3; min -95.5 kg, max +2.0 kg), which was reached 2.2 (s.d. 1.6) years after the surgery. Subjects regained approximately 12 kg (range 0.0-51.4 kg) by year 6. After correcting for multiple testing, the FTO SNP rs16945088 remained significantly associated with maximum weight loss (P = 0.0002), as minor allele carriers lost approximately 3 kg less compared with common allele homozygotes. This association was particularly evident in the banding surgery patients (P < 0.0001), whereas no significant association was found in the gastric bypass subjects. No other SNPs were associated with maximum weight loss. Furthermore, no SNPs were significantly associated with weight regain.
CONCLUSION: The FTO SNP rs16945088 was associated with maximum weight loss after banding surgery. We found no evidence that obesity-risk SNPs in FTO or other obesity candidate genes derived from genome-wide association studies are associated with maximum weight loss or weight regain over 6 years of follow-up in bariatric surgery patients. The potential role of other obesity genes remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733583     DOI: 10.1038/ijo.2010.166

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  40 in total

Review 1.  Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice?

Authors:  Josep Vidal; Amanda Jiménez; Ana de Hollanda; Lílliam Flores; Antonio Lacy
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

Review 2.  Precision behavioral medicine: Implications of genetic and genomic discoveries for behavioral weight loss treatment.

Authors:  Jeanne M McCaffery
Journal:  Am Psychol       Date:  2018-11

3.  Effects of RS9939609 gene variant in FTO gene on weight loss and cardiovascular risk factors after biliopancreatic diversion surgery.

Authors:  Daniel Antonio de Luis; Rocío Aller; Rosa Conde; Olatz Izaola; David Pacheco; Manuel Gonzalez Sagrado; David Primo
Journal:  J Gastrointest Surg       Date:  2012-02-04       Impact factor: 3.452

4.  Heritability of the weight loss response to gastric bypass surgery.

Authors:  Ida J Hatoum; Danielle M Greenawalt; Chris Cotsapas; Marc L Reitman; Mark J Daly; Lee M Kaplan
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

Review 5.  Role of eating disorders-related polymorphisms in obesity pathophysiology.

Authors:  Carolina Ferreira Nicoletti; Heitor Bernardes Pereira Delfino; Flávia Campos Ferreira; Marcela Augusta de Souza Pinhel; Carla Barbosa Nonino
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 6.  From obesity genetics to the future of personalized obesity therapy.

Authors:  Julia S El-Sayed Moustafa; Philippe Froguel
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

7.  The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study.

Authors:  Fatima Cody Stanford; Nasreen Alfaris; Gricelda Gomez; Elizabeth T Ricks; Alpana P Shukla; Kathleen E Corey; Janey S Pratt; Alfons Pomp; Francesco Rubino; Louis J Aronne
Journal:  Surg Obes Relat Dis       Date:  2016-10-27       Impact factor: 4.734

8.  The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux-en-Y Gastric Bypass Surgery.

Authors:  Nawfal W Istfan; Wendy A Anderson; Donald T Hess; Liqun Yu; Brian Carmine; Caroline M Apovian
Journal:  Obesity (Silver Spring)       Date:  2020-06       Impact factor: 5.002

Review 9.  Updates on Monogenic Obesity in a Multifactorial Disease.

Authors:  Jared Baxter; Priscila Rodrigues Armijo; Laura Flores; Crystal Krause; Sarah Samreen; Tiffany Tanner
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 10.  The importance of gene-environment interactions in human obesity.

Authors:  Hudson Reddon; Jean-Louis Guéant; David Meyre
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.